Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (Hereinafter: "Immunotherapy") in NSCLC in Palliative Therapy

NCT05426668 is registered in ClinicalTrials.gov with Karsten Gavenis as lead sponsor.

NCT NCT05426668
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05426668 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Validation of the TheraSure CNI-Monitor Under Immuno-checkpoint-therapy (Hereinafter: "Immunotherapy") in NSCLC in Palliative Therapy
Lead sponsor
Karsten Gavenis
Phase
Observational
Overall status
Recruiting
Start date
February 24, 2025
Completion date
February 29, 2028
Enrollment
170 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

nsclc